HLB will establish a corporate governance charter to define the correct management direction and
enhance its reputation as a trusted company. Through this charter,
we aim to share values with various stakeholders, including customers, shareholders, and employees.
| Recommendations | Acceptance | Note |
| Introduction of a corporate governance charter | ◯ | |
| Implementation of an employee code of ethics | ◯ | |
| Composition of more than half of the board of directors as outside directors | X | 7 Executives, 3 Independent |
| Regular board meeting | ◯ | Once a month |
| Segregation of CEO and Board Chairman | X | |
| Providing pre-meeting information about directors Before the board meeting | ◯ | 1 day prior |
| Disclosure of Board of directors regulations | ◯ | |
| Disclosure of board activity details, attendance rate, and pros and cons on major agenda items | ◯ | |
| Establishment of an Outside Director Candidate Recommendation Committee | ◯ | |
| Formation of Remuneration Committee | ◯ | |
| Disclosure of corporate governance evaluation grade | ◯ | |
| Formation of an Audit Committee consisting of all outside directors | ◯ | |
| Introduction of regulations on the roles and operating procedures of the board of directors and various committees | ◯ | |
| Enrollment for director’s liability insurance for damages at the company’s expense. | ◯ | Executive compensation liability insurance (Annual renewal) |
| Evaluation of Board of Directors activities | ◯ | |
| Preservation of the independence of external auditors | ◯ | |
| Certification of the accuracy and completeness of financial reporting by the CEO and CFO | ◯ | |
| Explanation of the difference between Best Practices and Standards | ◯ | Home page |
(Unit: KRW, case)
| Division | 2020 | 2021 | 2022 | |
| Violation of environmental laws |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Unfair trade practices, including anti-competitive behavior and monopolistic practices (including corruption and bribery) |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Violations in domestic marketing activities |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Violation of customer information protection regulations |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Violation of product information provision regulations |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Violation of regulations related to counterfeit products |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Violation of regulations related to clinical trials in developing countries |
Fine | - | - | - |
| Number of violations | - | - | - | |
| Number of incidents that violate legal regulations and self-regulation regarding the safety and health impacts of products and services | Fine | - | - | - |
| Number of violations | - | - | - |